| Alterations of the human gut microbiome in multiple sclerosis S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ... Nature communications 7 (1), 12015, 2016 | 1157 | 2016 |
| Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis R Raheja, K Regev, BC Healy, MA Mazzola, V Beynon, F Von Glehn, ... Muscle & nerve 58 (2), 261-269, 2018 | 94 | 2018 |
| Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse ALF Longhini, F von Glehn, CO Brandão, RFO de Paula, F Pradella, ... Journal of neuroinflammation 8, 1-4, 2011 | 76 | 2011 |
| Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders F Von Glehn, S Jarius, RP Cavalcanti Lira, MC Alves Ferreira, ... Multiple Sclerosis Journal 20 (9), 1189-1197, 2014 | 74 | 2014 |
| Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients F von Glehn, AS Farias, ACP de Oliveira, A Damasceno, ALF Longhini, ... Multiple Sclerosis Journal 18 (7), 1038-1041, 2012 | 74 | 2012 |
| Association between serum MicroRNAs and magnetic resonance imaging measures of multiple sclerosis severity K Regev, BC Healy, F Khalid, A Paul, R Chu, S Tauhid, S Tummala, ... JAMA neurology 74 (3), 275-285, 2017 | 71 | 2017 |
| Prognostic indicators for long-term disability in multiple sclerosis patients A Damasceno, F Von Glehn, CO Brandão, BP Damasceno, F Cendes Journal of the neurological sciences 324 (1-2), 29-33, 2013 | 60 | 2013 |
| Impact of electroacupuncture on quality of lifefor patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study JG Quispe-Cabanillas, A Damasceno, F von Glehn, CO Brandão, ... BMC complementary and alternative medicine 12, 1-7, 2012 | 54 | 2012 |
| Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7: 12015 S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ... | 45 | 2016 |
| Knee flexor strength and balance control impairment may explain declines during prolonged walking in women with mild multiple sclerosis C Ramari, AG Moraes, CB Tauil, F von Glehn, R Motl, AC de David Multiple sclerosis and related disorders 20, 181-185, 2018 | 36 | 2018 |
| Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of … DG Brum, ER Comini-Frota, CCF Vasconcelos, E Dias-Tosta Arquivos de Neuro-Psiquiatria 72, 152-156, 2014 | 34 | 2014 |
| Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: implications for the treatment of multiple sclerosis F Von Glehn, RPC Dias-Carneiro, AS Moraes, AS Farias, VAPG Silva, ... Multiple sclerosis and related disorders 23, 46-50, 2018 | 31 | 2018 |
| The suppressive effect of IL‐27 on encephalitogenic Th17 cells induced by multiwalled carbon nanotubes reduces the severity of experimental autoimmune encephalomyelitis AS Moraes, RFO Paula, F Pradella, MPA Santos, EC Oliveira, ... CNS neuroscience & therapeutics 19 (9), 682-687, 2013 | 30 | 2013 |
| Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis F Von Glehn, LM Santos, KE Balashov Immunotherapy 4 (10), 1053-1061, 2012 | 30 | 2012 |
| Monthly variation of multiple sclerosis activity in the southern hemisphere: analysis from 996 relapses in Brazil A Damasceno, F Von Glehn, L de Deus‐Silva, BP Damasceno European Journal of Neurology 19 (4), 660-662, 2012 | 24 | 2012 |
| Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders SL Apostolos-Pereira, L Campos Ferreira, M Boaventura, ... Neurology: Neuroimmunology & Neuroinflammation 8 (6), e1060, 2021 | 23 | 2021 |
| Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis AG Moraes, SGR Neri, RW Motl, CB Tauil, F von Glehn, ÉC Corrêa, ... Multiple sclerosis and related disorders 43, 102203, 2020 | 23 | 2020 |
| Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells MA Mazzola, R Raheja, K Regev, V Beynon, F von Glehn, A Paul, I Pierre, ... Multiple Sclerosis Journal 25 (1), 63-71, 2019 | 23 | 2019 |
| Th17 cells: A prognostic marker for MS rebound after natalizumab cessation? J Haas, K Schneider, A Schwarz, M Korporal-Kuhnke, S Faller, ... Multiple Sclerosis Journal 23 (1), 114-118, 2017 | 20 | 2017 |
| Cerebrospinal fluid analysis in the context of CNS demyelinating diseases SLA Matas, F Glehn, GBP Fernandes, CAS Soares Arquivos de neuro-psiquiatria 71, 685-688, 2013 | 20 | 2013 |
